Protein Sciences Corporation

Form 483 issued May 31, 2019 · Pearl River, New York

Observations
2
Pages
4
FEI number
3011286996

In short: On May 31, 2019, FDA issued a Form 483 with 2 observations to Protein Sciences Corporation in Pearl River, New York (FEI 3011286996). The investigator was Jacqueline Diaz-Albertini. Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Quality system and laboratory controls account for 2 of 2 observations.

Quality system1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Complaint investigations are incomplete, not closed out in a timely manner and standard operating procedures for…

  2. 02

    Observation 2: scanned text, readable in the full document.

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Protein Sciences Corporation?

FDA listed 2 observations on this Form 483, mostly about quality system and laboratory controls. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Protein Sciences Corporation?

Jacqueline Diaz-Albertini is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Protein Sciences Corporation inspected by FDA?

This Form 483 is dated May 31, 2019.

How do I get the full Form 483 for Protein Sciences Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free